Why We Invested in Resilient Lifescience — Preventing Opioid Overdose

1 min read

Excited to announce our investment in Resilient Lifescience, which is taking on the opioid epidemic by developing a wearable system to detect and automatically reverse overdoses. Tau Ventures is an AI-first fund in Silicon Valley investing primarily in seed and we occasionally take earlier or later bets when we see immense promise. We are also investing in US / Canada but in exceptional cases will consider a deal outside. Resilient was founded in 2022 in Pittsburgh and impressed us with (1) a strong need, (2) building an execution-focused team, and (3) their business strategy. 1) The Need The opioid crisis…...

This article is free to read

Login to read the full article


OR
Amit Garg I have been in Silicon Valley for 20 years -- at Samsung NEXT Ventures, running my own startup (as of May 2019 a series D that has raised $120M and valued at $450M), at Norwest Ventures, and doing product and analytics at Google. My academic training is BS in computer science and MS in biomedical informatics, both from Stanford, and MBA from Harvard. I speak natively 3 languages, live carbon-neutral, am a 70.3 Ironman finisher, and have built a hospital in rural India serving 100,000 people.